Jessica Dai, MD
Urology · Kirkland, WANPI 1407274905
Payments from drug & device makers
Across 29 payments — averaging $31.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$180
- Boston Scientific$112
- 180 Medical, Inc.$83
- Medtronic$78
- Progenics Pharmaceuticals, Inc.$59
- Tolmar Pharmaceuticals, Inc.$50
- plus $341 from 12 others
What the payments were for
- Food & beverage$87797%
- Education$263%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 4 | $180 |
| Boston Scientific | 4 | $112 |
| 180 Medical, Inc. | 3 | $83 |
| Medtronic | 1 | $78 |
| Progenics Pharmaceuticals, Inc. | 2 | $59 |
| Tolmar Pharmaceuticals, Inc. | 2 | $50 |
| Ferring Pharmaceuticals Inc. | 1 | $46 |
| Laborie Medical Technologies Corp. | 2 | $43 |
| Johnson & Johnson | 1 | $33 |
| BD | 1 | $29 |
| Endo USA, Inc. | 1 | $27 |
| EDAP Technomed Inc | 1 | $25 |
| Urogen Pharma, Inc. | 1 | $24 |
| Calyxo, Inc. | 1 | $24 |
| Tolmar, Inc. | 1 | $24 |
| Angiodynamics, Inc. | 1 | $23 |
| Pfizer | 1 | $22 |
| Axonics, Inc. | 1 | $21 |
How this compares
$902 in reported general payments places this provider in the 35th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $15,429 |
| Estradiol | 49 | $3,989 |
| Tamsulosin Hcl | 222 | $3,411 |
| Potassium Citrate ErPotassium Citrate | 44 | $2,405 |
| Finasteride | 99 | $1,234 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $535 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $236 |
| Cefdinir | 11 | $192 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 12 | $187 |
| Ciprofloxacin Hcl | 27 | $155 |
| Oxycodone Hcl | 58 | $112 |
| Ibuprofen | 24 | $66 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $44 |
| Levofloxacin | 18 | $22 |
Paid to pharmacies, not to this prescriber.
Other urology in Kirkland
- Kevin OstrowskiKirkland$64K
- Sabrina StairKirkland$9K
- James PorterSeattle$2.6M
- Shane PearceSpokane$1.8M
- Raymond LanceSpokane$1.2M
- Jonathan WrightSeattle$1M
- Thomas WalshSeattle$388K
- Una LeeSeattle$236K
- Marah HehemannSeattle$213K
- Sarah PsutkaSeattle$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.